- Home
- HAFN vs ENOV Comparison
HAFN vs ENOV Comparison
Compare HAFN & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAFN
- ENOV
- Stock Information
- Founded
- HAFN 2012
- ENOV 1995
- Country
- HAFN Bermuda
- ENOV United States
- Employees
- HAFN N/A
- ENOV N/A
- Industry
- HAFN
- ENOV Fluid Controls
- Sector
- HAFN
- ENOV Industrials
- Exchange
- HAFN Nasdaq
- ENOV Nasdaq
- Market Cap
- HAFN 2.8B
- ENOV 2.4B
- IPO Year
- HAFN N/A
- ENOV 2008
- Fundamental
- Price
- HAFN $5.44
- ENOV $46.59
- Analyst Decision
- HAFN Strong Buy
- ENOV Strong Buy
- Analyst Count
- HAFN 2
- ENOV 8
- Target Price
- HAFN $8.25
- ENOV $67.00
- AVG Volume (30 Days)
- HAFN 2.5M
- ENOV 1.2M
- Earning Date
- HAFN 02-27-2025
- ENOV 02-20-2025
- Dividend Yield
- HAFN 27.92%
- ENOV N/A
- EPS Growth
- HAFN N/A
- ENOV N/A
- EPS
- HAFN 1.69
- ENOV N/A
- Revenue
- HAFN $3,039,225,000.00
- ENOV $2,001,668,000.00
- Revenue This Year
- HAFN N/A
- ENOV $25.59
- Revenue Next Year
- HAFN N/A
- ENOV $5.74
- P/E Ratio
- HAFN $3.21
- ENOV N/A
- Revenue Growth
- HAFN 15.24
- ENOV 20.52
- 52 Week Low
- HAFN $4.99
- ENOV $38.27
- 52 Week High
- HAFN $8.99
- ENOV $65.03
- Technical
- Relative Strength Index (RSI)
- HAFN N/A
- ENOV 58.02
- Support Level
- HAFN N/A
- ENOV $45.02
- Resistance Level
- HAFN N/A
- ENOV $46.34
- Average True Range (ATR)
- HAFN 0.00
- ENOV 1.55
- MACD
- HAFN 0.00
- ENOV 0.27
- Stochastic Oscillator
- HAFN 0.00
- ENOV 76.36
About HAFN Hafnia Limited Common Shares
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.